ID: 130058992 | ATAC-STARR-seq lymphoblastoid active region 10814 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (50274382..50274451) | | |
ID: 130058991 | ATAC-STARR-seq lymphoblastoid active region 10812 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (50264448..50264627) | | |
ID: 130058990 | ATAC-STARR-seq lymphoblastoid active region 10811 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (50262145..50262214) | | |
ID: 130058989 | ATAC-STARR-seq lymphoblastoid silent region 7478 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (50246027..50246286) | | |
ID: 130058988 | ATAC-STARR-seq lymphoblastoid active region 10810 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (50210002..50210061) | | |
ID: 127883953 | H3K4me1 hESC enhancer GRCh37_chr16:50317845-50318346 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (50283934..50284435) | | |
ID: 127883952 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr16:50306047-50306881 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (50272136..50272970) | | |
ID: 127883951 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr16:50305212-50306046 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (50271301..50272135) | | |
ID: 127883950 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr16:50299606-50300199 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (50265695..50266323) | | |
ID: 127883949 | H3K4me1 hESC enhancer GRCh37_chr16:50288095-50288594 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (50254184..50254683) | | |
ID: 127883948 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr16:50280376-50281087 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (50246307..50247176) | | |
ID: 127883947 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr16:50278951-50279662 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (50245040..50245751) | | |
ID: 127883946 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr16:50278238-50278950 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (50244327..50245039) | | |
ID: 126862343 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr16:50353005-50354204 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (50319094..50320293) | | |
ID: 126862342 | MED14-independent group 3 enhancer GRCh37_chr16:50347343-50348542 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (50313432..50314631) | | |
ID: 125177306 | Sharpr-MPRA regulatory region 8986 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (50210578..50210872) | | |
ID: 121847987 | Sharpr-MPRA regulatory region 2137 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (50309838..50310132) | | |
ID: 102465462 | microRNA 6771 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (50292616..50292675) | hsa-mir-6771 | |
ID: 64282 | terminal nucleotidyltransferase 4B [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (50152911..50235310) | PAPD5, TRF4-2, TUT3 | 605540 |
ID: 29117 | bromodomain containing 7 [Homo sapiens (human)] | Chromosome 16, NC_000016.10 (50315957..50368988, complement) | BP75, CELTIX1, NAG4, SMARCI1 | 618489 |